{"key":"eloralintide","slug":"eloralintide","name":"Eloralintide","other_names":[],"kind":"single","area":{"slug":"metabolic","name":"Metabolic"},"classification":"Long-acting amylin receptor agonist","standing":{"id":"phase-2","label":"Phase 2 trials","rank":3},"summary":"A once-weekly amylin receptor agonist with published phase 2 results in obesity.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":10,"in_humans":7,"clinical_trials":3},"retired":false,"updated_at":"2026-11-19T00:17:24.814Z","url":"https://pepts.wiki/compounds/eloralintide","article":null,"evidence":{"query":"(\"Eloralintide\"[tiab])","fetched_at":"2026-11-16T22:55:19.426Z","counts":{"rcts":3,"human":7,"total":10,"reviews":6,"clinicalTrials":3},"years":[{"year":2012,"count":0},{"year":2013,"count":0},{"year":2014,"count":0},{"year":2015,"count":0},{"year":2016,"count":0},{"year":2017,"count":0},{"year":2018,"count":0},{"year":2019,"count":0},{"year":2020,"count":0},{"year":2021,"count":0},{"year":2022,"count":0},{"year":2023,"count":0},{"year":2024,"count":0},{"year":2025,"count":2},{"year":2026,"count":8}],"top":[{"doi":"10.1016/j.molmet.2025.102271","url":"https://pubmed.ncbi.nlm.nih.gov/41109426/","kind":"rct","pmid":"41109426","year":2025,"title":"Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept","venue":"Molecular metabolism","authors":"Briere DA, Qu H, Lansu K, et al."},{"doi":"10.1016/S0140-6736(25)02155-5","url":"https://pubmed.ncbi.nlm.nih.gov/41207310/","kind":"rct","pmid":"41207310","year":2025,"title":"Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial","venue":"Lancet (London, England)","authors":"Billings LK, Hsia S, Bays H, et al."},{"doi":"10.1111/dom.70439","url":"https://pubmed.ncbi.nlm.nih.gov/41559929/","kind":"rct","pmid":"41559929","year":2026,"title":"Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept","venue":"Diabetes, obesity & metabolism","authors":"Bhattachar S, Tham LS, Tidemann-Miller B, et al."},{"doi":"10.1002/edm2.70247","url":"https://pubmed.ncbi.nlm.nih.gov/42175595/","kind":"review","pmid":"42175595","year":2026,"title":"Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis","venue":"Endocrinology, diabetes & metabolism","authors":"Kamrul-Hasan ABM, Khalil I, Mahajan K, et al."},{"doi":"10.1016/j.peptides.2026.171480","url":"https://pubmed.ncbi.nlm.nih.gov/41747885/","kind":"review","pmid":"41747885","year":2026,"title":"Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes","venue":"Peptides","authors":"Bailey CJ, Flatt PR, Conlon JM"},{"doi":"10.1007/s13300-026-01921-0","url":"https://pubmed.ncbi.nlm.nih.gov/42803913/","kind":"review","pmid":"42803913","year":2026,"title":"New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus","venue":"Diabetes therapy : research, treatment and education of diabetes and related disorders","authors":"Panou T, Gouveri E, Popovic DS, et al."},{"doi":"10.1111/dom.71074","url":"https://pubmed.ncbi.nlm.nih.gov/42452898/","kind":"review","pmid":"42452898","year":2026,"title":"Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials","venue":"Diabetes, obesity & metabolism","authors":"Alhazmi A, le Roux CW"},{"doi":"10.1016/j.phrs.2026.108382","url":"https://pubmed.ncbi.nlm.nih.gov/42586227/","kind":"review","pmid":"42586227","year":2026,"title":"Beyond GLP-1: Amylin-based pharmacotherapy and the search for better-tolerated weight-loss drugs","venue":"Pharmacological research","authors":"Fischer SL, Borner T"}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}